Outcome | Exposure group | Incidence cases | Person-years | Incidence density (/104 person-years) | HR (95% CI) | P |
---|---|---|---|---|---|---|
Stroke | ||||||
Overall | ||||||
hs-CRP < 1 mg/L | 171 | 28400.96 | 60.21 | Ref | ||
hs-CRP ≥ 1 mg/L | 236 | 21631.78 | 109.10 | 1.25 (1.03–1.54) | 0.030* | |
Dyslipidemia | ||||||
Yes | ||||||
hs-CRP < 1 mg/L | 63 | 8788.92 | 71.68 | Ref | ||
hs-CRP ≥ 1 mg/L | 101 | 9108.70 | 110.88 | 1.19 (0.86–1.66) | 0.296 | |
No | ||||||
hs-CRP < 1 mg/L | 108 | 19612.03 | 55.07 | Ref | ||
hs-CRP ≥ 1 mg/L | 135 | 12523.08 | 107.80 | 1.34 (1.03–1.74) | 0.030* | |
P for heterogeneity | 0.583 | |||||
CHD | ||||||
Overall | ||||||
hs-CRP < 1 mg/L | 103 | 28574.96 | 36.05 | Ref | ||
hs-CRP ≥ 1 mg/L | 138 | 22005.62 | 67.71 | 1.25 (0.96–1.64) | 0.098 | |
Dyslipidemia | ||||||
Yes | 47 | 8772.85 | 53.57 | Ref | ||
hs-CRP < 1 mg/L | 63 | 9353.41 | 67.36 | 1.06 (0.72–1.58) | 0.759 | |
hs-CRP ≥ 1 mg/L | ||||||
No | ||||||
hs-CRP < 1 mg/L | 56 | 19802.11 | 28.28 | Ref | ||
hs-CRP ≥ 1 mg/L | 75 | 12652.21 | 59.28 | 1.41 (0.99–2.02) | 0.058 | |
P for heterogeneity | 0.307 | |||||
CVD | ||||||
Overall | ||||||
hs-CRP < 1 mg/L | 240 | 27732.35 | 86.54 | Ref | ||
hs-CRP ≥ 1 mg/L | 327 | 20607.06 | 158.68 | 1.30 (1.09–1.54) | 0.004* | |
Dyslipidemia | ||||||
Yes | ||||||
hs-CRP < 1 mg/L | 98 | 8437.70 | 116.15 | Ref | ||
hs-CRP ≥ 1 mg/L | 147 | 8667.95 | 169.59 | 1.17 (0.89–1.53) | 0.255 | |
No | ||||||
hs-CRP < 1 mg/L | 142 | 19294.65 | 73.60 | Ref | ||
hs-CRP ≥ 1 mg/L | 180 | 11939.11 | 150.77 | 1.42 (1.14–1.79) | 0.002* | |
P for heterogeneity | 0.283 |